{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T02:15:01Z","timestamp":1777342501958,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["High Blood Press Cardiovasc Prev"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/bf03297635","type":"journal-article","created":{"date-parts":[[2013,2,21]],"date-time":"2013-02-21T18:01:17Z","timestamp":1361469677000},"page":"229-235","source":"Crossref","is-referenced-by-count":6,"title":["Association between Low Red Blood Cell 5-Methyltetrahydrofolate and Hyperhomocysteinaemia with Hypertension"],"prefix":"10.1007","volume":"19","author":[{"given":"Jamal","family":"Golbahar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esmael","family":"Mostafavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,29]]},"reference":[{"key":"7635_CR1","doi-asserted-by":"crossref","first-page":"314","DOI":"10.5694\/j.1326-5377.2004.tb06296.x","volume":"181","author":"GJ Hankey","year":"2004","unstructured":"Hankey GJ, Eikelboom JW, Ho WK, et al. Clinical usefulness of plasma homocysteine in vascular disease. Med J Aust 2004; 181: 314\u20138","journal-title":"Med J Aust"},{"key":"7635_CR2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11883-004-0097-3","volume":"6","author":"DK Kalra","year":"2004","unstructured":"Kalra DK. Homocysteine and cardiovascular disease. Curr Atheroscler Rep 2004; 6: 101\u20136","journal-title":"Curr Atheroscler Rep"},{"key":"7635_CR3","first-page":"1775","volume":"277","author":"IM Graham","year":"1997","unstructured":"Graham IM, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997; 277: 1775\u201381","journal-title":"The European Concerted Action Project. JAMA"},{"key":"7635_CR4","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/bmj.325.7374.1202","volume":"325","author":"DS Wald","year":"2002","unstructured":"Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 2002; 325: 1202\u20136","journal-title":"BMJ"},{"key":"7635_CR5","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jnutbio.2003.08.010","volume":"15","author":"SJ Moat","year":"2004","unstructured":"Moat SJ, Lang D, McDowell IF, et al. Folate, homocysteine, endothelial function and cardiovascular disease. J Nutr Biochem 2004; 15: 64\u201379","journal-title":"J Nutr Biochem"},{"key":"7635_CR6","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S0140-6736(96)12049-3","volume":"349","author":"AM Molloy","year":"1997","unstructured":"Molloy AM, Daly S, Mills JL. Thermolabile variant of 5,10 methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations. Lancet 1997; 349: 1591\u20133","journal-title":"Lancet"},{"key":"7635_CR7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00380-004-0823-3","volume":"20","author":"J Golbahar","year":"2005","unstructured":"Golbahar J, Aminzadeh MA, Sharifkazemi MB, et al. Association of red blood cell 5-methyltetrahydrofolate and severity of coronary artery disease: a cross-sectional study from Shiraz, southern Iran. Heart Vessels 2005; 20: 203\u20136","journal-title":"Heart Vessels"},{"key":"7635_CR8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000086460","volume":"42","author":"J Golbahar","year":"2005","unstructured":"Golbahar J, Rezaian G, Fathi Z, et al. Association of low red blood cell folate concentrations with coronary artery disease in Iranians: a matched casecontrol study. J Vasc Res 2005; 42: 325\u201330","journal-title":"J Vasc Res"},{"key":"7635_CR9","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1161\/01.CIR.96.6.1745","volume":"96","author":"K Sutton-Tyrrell","year":"1997","unstructured":"Sutton-Tyrrell K, Bostom A, Selhub J, et al. High homocysteine levels are independently related to isolated systolic hypertension in older adults. Circulation 1997; 96: 1745\u20139","journal-title":"Circulation"},{"key":"7635_CR10","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1177\/0091270003258190","volume":"43","author":"R Rodrigo","year":"2003","unstructured":"Rodrigo R, Passalacqua W, Araya J, et al. Homocysteine and essential hypertension. J Clin Pharmacol 2003; 43: 1299\u2013306","journal-title":"J Clin Pharmacol"},{"key":"7635_CR11","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0895-7061(00)01321-2","volume":"14","author":"GY Lip","year":"2001","unstructured":"Lip GY, Edmunds E, Martin SC, et al. A pilot study of homocyst(e)ine levels in essential hypertension: relationship to von Willebrand factor, an index of endothelial damage. Am J Hypertens 2001; 14: 627\u201331","journal-title":"Am J Hypertens"},{"key":"7635_CR12","first-page":"1526","volume":"274","author":"O Nygard","year":"1995","unstructured":"Nygard O, Vollset SE, Refsum H, et al. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 1995; 274: 1526\u201333","journal-title":"The Hordaland Homocysteine Study. JAMA"},{"key":"7635_CR13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0021-9150(94)05481-W","volume":"114","author":"MR Malinow","year":"1995","unstructured":"Malinow MR, Levenson J, Giral P, et al. Role of blood pressure, uric acid, and hemorheological parameters on plasma homocyst(e)ine concentration. Atherosclerosis 1995; 114: 175\u201383","journal-title":"Atherosclerosis"},{"key":"7635_CR14","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/sj.jhh.1001911","volume":"19","author":"H Fakhrzadeh","year":"2005","unstructured":"Fakhrzadeh H, Ghotbi S, Pourebrahim R, et al. Plasma homocysteine concentration and blood pressure in healthy Iranian adults: the Tehran Homocysteine Survey (2003\u20132004). J Hum Hypertens 2005; 19: 869\u201376","journal-title":"J Hum Hypertens"},{"key":"7635_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000160079","volume":"2","author":"X Ng","year":"2009","unstructured":"Ng X, Boyd L, Dufficy L, et al. Folate nutritional genetics and risk for hypertension in an elderly population sample. J Nutrigenet Nutrigenomics 2009; 2: 1\u20138","journal-title":"J Nutrigenet Nutrigenomics"},{"key":"7635_CR16","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.3945\/ajcn.111.027250","volume":"95","author":"P Xun","year":"2012","unstructured":"Xun P, Liu K, Loria CM, et al. Folate intake and incidence of hypertension among American young adults: a 20-y follow-up study. Am J Clin Nutr 2012; 95: 1023\u201330","journal-title":"Am J Clin Nutr"},{"key":"7635_CR17","first-page":"155","volume":"9","author":"H Jakubowski","year":"2008","unstructured":"Jakubowski H. The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease. J Physiol Pharmacol 2008; 59 Suppl. 9: 155\u201367","journal-title":"J Physiol Pharmacol"},{"key":"7635_CR18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1023\/A:1009652011466","volume":"5","author":"P Mercie","year":"2000","unstructured":"Mercie P, Garnier O, Lascoste L, et al. Homocysteine-thiolactone induces caspase-independent vascular endothelial cell death with apoptotic features. Apoptosis 2000; 5: 403\u201311","journal-title":"Apoptosis"},{"key":"7635_CR19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11010-006-9204-9","volume":"291","author":"M Kerkeni","year":"2006","unstructured":"Kerkeni M, Tnani M, Chuniaud L, et al. Comparative study on in vitro effects of homocysteine thiolactone and homocysteine on HUVEC cells: evidence for a stronger proapoptotic and proinflammative homocysteine thiolactone. Mol Cell Biochem 2006; 291: 119\u201326","journal-title":"Mol Cell Biochem"},{"key":"7635_CR20","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3317\/jraas.2006.039","volume":"7","author":"S Kassab","year":"2006","unstructured":"Kassab S, Garadah T, Abu-Hijleh M, et al. The angiotensin type 1 receptor antagonist valsartan attenuates pathological ventricular hypertrophy induced by hyperhomocysteinemia in rats. J Renin Angiotensin Aldosterone Syst 2006; 7: 206\u201311","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"7635_CR21","first-page":"195","volume-title":"Folic acid metabolism in health and disease","author":"V Herbert","year":"1990","unstructured":"Herbert V. Development of human folate deficiency. In: Picano MF, Stockstad ELR, Gregory JF, editors. Folic acid metabolism in health and disease. New York: Wiley-Liss, 1990: 195\u2013210"},{"key":"7635_CR22","first-page":"394","volume-title":"Hematology: basic principles and practice","author":"AC Antony","year":"1991","unstructured":"Antony AC. Megaloblastic anemia. In: Hoffman R, Benz EJ, Shattil S, et al., editors. Hematology: basic principles and practice. Philadelphia (PA): Churchill Livingstone, 1991: 394\u2013423"},{"key":"7635_CR23","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1093\/jn\/131.12.3277","volume":"131","author":"SF Choumenkovitch","year":"2001","unstructured":"Choumenkovitch SF, Jacques PF, Nadeau MR, et al. Folic acid fortification increases red blood cell folate concentrations in the Framingham study. J Nutr 2001; 131: 3277\u201380","journal-title":"J Nutr"},{"key":"7635_CR24","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1177\/0003319710380681","volume":"62","author":"N Khandanpour","year":"2011","unstructured":"Khandanpour N, Jennings B, Armon MP, et al. Do novel risk biomarkers reflect the severity of peripheral arterial disease? Angiology 2011; 62: 126\u201333","journal-title":"Angiology"},{"key":"7635_CR25","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jpeds.2003.12.049","volume":"144","author":"AS Pena","year":"2004","unstructured":"Pena AS, Wiltshire E, Gent R, et al. Folic acid improves endothelial function in children and adolescents with type 1 diabetes. J Pediatr 2004; 144: 500\u20134","journal-title":"J Pediatr"},{"key":"7635_CR26","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1007\/s00125-002-0862-1","volume":"45","author":"RW Etten van","year":"2002","unstructured":"van Etten RW, de Koning EJ, Verhaar MC, et al. Impaired NO-dependent vasodilation in patients with type II (non-insulin-dependent) diabetes mellitus is restored by acute administration of folate. Diabetologia 2002; 45: 1004\u201310","journal-title":"Diabetologia"},{"key":"7635_CR27","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/01.CIR.97.3.237","volume":"97","author":"MC Verhaar","year":"1998","unstructured":"Verhaar MC, Wever RM, Kastelein JJ, et al. 5-Methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia. Circulation 1998; 97: 237\u201341","journal-title":"Circulation"},{"key":"7635_CR28","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/01.ATV.20.1.185","volume":"20","author":"HW Wilmink","year":"2000","unstructured":"Wilmink HW, Stroes ESG, Erkelens WD, et al. Influence of folic acid on postprandial endothelial dysfunction. Arterioscler Thromb Vasc Biol 2000; 20: 185\u20138","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7635_CR29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1161\/hc0102.101388","volume":"1","author":"SN Doshi","year":"2002","unstructured":"Doshi SN, McDowell IFW, Moat SJ, et al. Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation 2002; 1: 22\u20136","journal-title":"Circulation"},{"key":"7635_CR30","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/01.RES.86.11.1129","volume":"86","author":"ES Stroes","year":"2000","unstructured":"Stroes ES, van Faassen EE, Yo M, et al. Folic acid reverts dysfunction of endothelial nitric oxide synthase. Circ Res 2000; 86: 1129\u201334","journal-title":"Circ Res"},{"key":"7635_CR31","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1161\/hc3501.095358","volume":"104","author":"T Gori","year":"2001","unstructured":"Gori T, Burstein JM, Ahmed S, et al. Folic acid prevents nitroglycerin-induced nitric oxide synthase dysfunction and nitrate tolerance: a human in vivo study. Circulation 2001; 104: 1119\u201323","journal-title":"Circulation"},{"key":"7635_CR32","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1093\/jn\/138.8.1456","volume":"138","author":"RM Winkels","year":"2008","unstructured":"Winkels RM, Brouwer IA, Verhoef P, et al. Gender and body size affect the response of erythrocyte folate to folic acid treatment. J Nutr 2008; 138: 1456\u201361","journal-title":"J Nutr"},{"key":"7635_CR33","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/ajh.2011.133","volume":"24","author":"Y Tamai","year":"2011","unstructured":"Tamai Y, Wada K, Tsuji M, et al. Dietary intake of vitamin B12 and folic acid is associated with lower blood pressure in Japanese preschool children. Am J Hypertens 2011; 24: 1215\u201321","journal-title":"Am J Hypertens"},{"key":"7635_CR34","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/ejcn.2009.58","volume":"63","author":"A Cagnacci","year":"2009","unstructured":"Cagnacci A, Cannoletta M, Volpe A. High-dose short-term folate administration modifies ambulatory blood pressure in postmenopausal women: a placebo-controlled study. Eur J Clin Nutr 2009; 63: 1266\u20138","journal-title":"Eur J Clin Nutr"},{"key":"7635_CR35","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3945\/ajcn.111.026245","volume":"95","author":"CP Wilson","year":"2012","unstructured":"Wilson CP, Ward M, McNulty H, et al. Riboflavin offers a targeted strategy for managing hypertension in patients with the MTHFR 677TT genotype: a 4-y follow-up. Am J Clin Nutr 2012; 95: 766\u201372","journal-title":"Am J Clin Nutr"}],"container-title":["High Blood Pressure & Cardiovascular Prevention"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03297635.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03297635\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03297635","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T17:15:17Z","timestamp":1595438117000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03297635"}},"subtitle":["A Cross-Sectional Study"],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["7635"],"URL":"https:\/\/doi.org\/10.1007\/bf03297635","relation":{},"ISSN":["1120-9879","1179-1985"],"issn-type":[{"value":"1120-9879","type":"print"},{"value":"1179-1985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}